Kennedy Lewis Management’s Rapid Micro Biosystems RPID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.4M Hold
4,939,931
20.1% 2
2024
Q2
$3.26M Hold
4,939,931
14.06% 2
2024
Q1
$4.79M Hold
4,939,931
20.73% 2
2023
Q4
$3.66M Hold
4,939,931
20.25% 2
2023
Q3
$5.34M Hold
4,939,931
25.51% 2
2023
Q2
$4.94M Hold
4,939,931
16.97% 3
2023
Q1
$6.47M Hold
4,939,931
17.03% 3
2022
Q4
$5.58M Hold
4,939,931
8.41% 4
2022
Q3
$16M Hold
4,939,931
18.21% 3
2022
Q2
$21.2M Buy
4,939,931
+3,074,519
+165% +$14.3M 23.35% 2
2022
Q1
$12.7M Buy
1,865,412
+1,506,262
+419% +$11.1M 7.87% 3
2021
Q4
$3.82M Buy
+359,150
New +$5.61M 2.55% 4

Other funds holding RPID

Kennedy Lewis Management's RPID Position: Q3 2024 in Review

Kennedy Lewis Management held its Rapid Micro Biosystems (RPID) position steady in Q3 2024 at 4,939,931 shares worth $4.4M. The position accounts for 20.1% of the portfolio, ranked #2.

Kennedy Lewis Management first reported a position in RPID in Q4 2021 and has held it in 12 quarters since. The position peaked at $21.2M in Q2 2022. 19 funds tracked by Wall St. Rank hold RPID as of Q3 2024.

  • Kennedy Lewis Management held 4,939,931 shares of Rapid Micro Biosystems worth $4.4M as of Q3 2024.
  • Kennedy Lewis Management left its Rapid Micro Biosystems share count unchanged in Q3 2024.
  • Rapid Micro Biosystems made up 20.1% of Kennedy Lewis Management's portfolio in Q3 2024, its #2 holding.
  • Kennedy Lewis Management first reported a position in Rapid Micro Biosystems in Q4 2021 and has held it in 12 quarters since.
  • Kennedy Lewis Management's Rapid Micro Biosystems position peaked at $21.2M in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2024.

Based on Kennedy Lewis Management's 13F filing for Q3 2024, filed 18 Oct 2024.